Federal Court: CBD Drug Maker GW Pharmaceuticals Didn’t Violate Extraction Patent
By
Posted on
U.S. District Judge Alan D. Albright ruled in favor of GW on Feb. 25th
A Texas court has dismissed a lawsuit accusing pharmaceutical CBD maker GW Pharmaceuticals of violating another company’s patented method of cannabidiol extraction for its epilepsy drug Epidiolex.
The 2020 lawsuit from Canadian cannabis producer Canopy Growth alleged that GW, now part of Jazz Pharmaceuticals, knowingly used a Canopy-patented cannabis extraction method.
U.S. District Judge Alan D. Albright ruled in favor of GW on Feb. 25. His ruling leaves a path for Canopy to appeal he decision.
To Read The Rest Of This Article On Hemp Industry Daily, Click Here
